Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasm of Thorax”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT05840770
What this trial is testing

Cemiplimab for the Treatment of Untreated Brain Metastases From PD-L1 >= 50% Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Lung Non-Small Cell CarcinomaMetastatic Malignant Neoplasm in the BrainStage IV Lung Cancer AJCC v8
City of Hope Medical Center
Early research (Phase 1)Study completedNCT00879866
What this trial is testing

EMD 521873 Plus Radiotherapy in Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung CancerNon Small Cell Lung Cancer
Merck KGaA, Darmstadt, Germany 15
Early research (Phase 1)Looking for participantsNCT03760575
What this trial is testing

Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)

Who this might be right for
Mesotheliomas Pleural
Abramson Cancer Center at Penn Medicine 20
Large-scale testing (Phase 3)Study completedNCT02709512
What this trial is testing

Ph 2/3 Study in Subjects With MPM to Assess ADI-PEG 20 With Pemetrexed and Cisplatin

Who this might be right for
Mesothelioma
Polaris Group 249
Testing effectiveness (Phase 2)Looking for participantsNCT05269381
What this trial is testing

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more
Mayo Clinic 138
Testing effectiveness (Phase 2)UnknownNCT00644319
What this trial is testing

Ibuprofen or Morphine in Treating Pain in Patients Undergoing Pleurodesis for Malignant Pleural Effusion

Who this might be right for
Metastatic Cancer
Oxford University Hospitals NHS Trust 320
Testing effectiveness (Phase 2)Ended earlyNCT03502746
What this trial is testing

Phase II Nivolumab and Ramucirumab for Patients With Previously-Treated Mesothelioma

Who this might be right for
Mesothelioma, Malignant
Arkadiusz Z. Dudek, MD 34
Not applicableStudy completedNCT03004586
What this trial is testing

Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Using a 22 vs 25-Gauge Needle

Who this might be right for
Malignant Neoplasm of Respiratory and Intrathoracic Organ CarcinomaLung Cancer
M.D. Anderson Cancer Center 61
Early research (Phase 1)Study completedNCT06469138
What this trial is testing

Investigate 14C-bemcentinib in Healthy Male Subjects

Who this might be right for
Non-Small Cell Lung CancerMetastatic MelanomaAcute Myeloid Leukemia+5 more
BerGenBio ASA 6
Early research (Phase 1)Looking for participantsNCT03917043
What this trial is testing

APG-2449 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid CancerNon Small Cell Lung CancerEsophageal Cancer+2 more
Ascentage Pharma Group Inc. 165
Not applicableUnknownNCT06451536
What this trial is testing

Ga-68 FAPI PET Before Immunotherapy

Who this might be right for
Mesotheliomas Pleural
Ankara University 30
Testing effectiveness (Phase 2)UnknownNCT02650544
What this trial is testing

Efficacy and Safety Analyses of Mirtazapine in NSCLC Patients With Depression

Who this might be right for
Carcinoma, Non-Small-Cell LungDepression
Sun Yat-sen University 236
Not applicableStudy completedNCT05224271
What this trial is testing

Evaluating Patient Reported Outcomes in Radiation Therapy, the PRO-RT Study

Who this might be right for
Breast CarcinomaHead and Neck CarcinomaLung Carcinoma+1 more
Mayo Clinic 18
Testing effectiveness (Phase 2)Study completedNCT04749602
What this trial is testing

Intrapleural Instillation of the Nivolumab in Cancer Patients With Pleural Effusion.

Who this might be right for
Renal Cell Cancer MetastaticNon-small Cell Lung Cancer MetastaticPleural Effusion, Malignant
Kidney Cancer Research Bureau 26
Early research (Phase 1)Active Not RecruitingNCT05163028
What this trial is testing

A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations

Who this might be right for
Non Small Cell Lung CancerColorectal CancerPancreatic Cancer+4 more
HUYABIO International, LLC. 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT03007030
What this trial is testing

Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery

Who this might be right for
CD30-Positive Neoplastic Cells PresentMalignant Mesothelioma
M.D. Anderson Cancer Center 25
Early research (Phase 1)Ended earlyNCT01143545
What this trial is testing

Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas

Who this might be right for
Lung CancerEsophageal CancerMalignant Pleural Mesothelioma+2 more
National Cancer Institute (NCI) 10
Not applicableLooking for participantsNCT04806412
What this trial is testing

Oncodrivers in Malignant Pleural Effusions Associated With Non-small Cell Lung Cancer: A Prospective Study.

Who this might be right for
Malignant Pleural EffusionNon-small Cell Lung Cancer
Naestved Hospital 100
Early research (Phase 1)Study completedNCT02922764
What this trial is testing

RGX-104 in Patients With Advanced Lung & Endometrial Cancer

Who this might be right for
Endometrial CancerEndometrial Cancer RecurrentLung Cancer Recurrent+3 more
Inspirna, Inc. 146
Early research (Phase 1)Looking for participantsNCT07619599
What this trial is testing

A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab

Who this might be right for
Metastatic Lung Non-Small Cell CarcinomaMetastatic Malignant Neoplasm in the BrainOligoprogressive Lung Non-Small Cell Carcinoma+1 more
City of Hope Medical Center 6
Next Page